World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
57790
World Ranking
4487
National Ranking
442

Overview

David J. Kerr is affiliated with the University of Oxford in the United Kingdom. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a notable focus on Oncology, Pathology and Forensic Medicine, Molecular Biology, Cancer Research, and Radiology, Nuclear Medicine and Imaging as subfields of study.

The scientist's work frequently explores topics such as genetic factors in colorectal cancer, colorectal cancer treatments and studies, cancer genomics and diagnostics, radiomics and machine learning in medical imaging, colorectal cancer screening and detection, colorectal cancer surgical treatments, and the impacts of COVID-19 on healthcare.

David J. Kerr has a significant publication record in several scientific venues, including:

  • The Lancet Oncology
  • The Lancet
  • JCO Global Oncology
  • Journal of Clinical Oncology
  • Nature Genetics

Among the recent papers associated with the research domain, several stand out due to their contribution to ongoing scientific discussions:

  • COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study, 2020, The Lancet
  • COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study, 2020, The Lancet Oncology
  • Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer, 2021, The Lancet Oncology
  • Designing deep learning studies in cancer diagnostics, 2021, Nature reviews. Cancer
  • Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries, 2022, Nature Genetics

Collaboration plays a prominent role in their work. Frequent co-authors include Rachel Kerr, David N. Church, Claire Palles, Håvard E. Danielsen, and Tim Maughan.

Best Publications

  • A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

    John P. Neoptolemos;Deborah D. Stocken;Helmut Friess;Claudio Bassi

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

    Richard Gray;Jennifer Barnwell;Christopher McConkey

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

    J. P. Neoptolemos;Janet A. Dunn;D. D. Stocken;J. Almond

  • COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.

    Lennard Y.W. Lee;Jean Baptiste Cazier;Vasileios Angelis;Roland Arnold

  • Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

    Claire Palles;Jean-Baptiste Cazier;Kimberley M Howarth;Enric Domingo

  • A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21.

    Ian Tomlinson;Ian Tomlinson;Emily Webb;Luis Carvajal-Carmona;Peter Broderick

  • Genetic prognostic and predictive markers in colorectal cancer.

    Axel Walther;Elaine Johnstone;Charles Swanton;Charles Swanton;Rachel Midgley

  • Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.

    D R Ferry;A Smith;J Malkhandi;D W Fyfe

  • Delivering affordable cancer care in high-income countries

    Richard Sullivan;Jeffrey Peppercorn;Karol Sikora;John Zalcberg

  • Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel J. Sargent;Harry S. Wieand;Daniel G. Haller;Richard Gray

  • Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

    Gordon Hutchins;Katie Southward;Kelly Handley;Laura Magill

  • Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

    John P. Neoptolemos;Deborah D. Stocken;Janet A. Dunn;Jennifer Almond

  • A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

    Ian P.M. Tomlinson;Emily Webb;Luis Carvajal-Carmona;Peter Broderick

  • Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

    Ramon Salazar;Paul Roepman;Gabriel Capella;Victor Moreno

  • A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk

    Peter Broderick;Luis Carvajal-Carmona;Luis Carvajal-Carmona;Alan M. Pittman;Emily Webb

  • Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer

    Richard S. Houlston;Emily Webb;Peter Broderick;Alan M. Pittman

  • Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey

    P Stone;A Richardson;E Ream;AG Smith

Frequent Co-Authors

Ian Tomlinson
Ian Tomlinson University of Oxford
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research
Lawrence S. Young
Lawrence S. Young University of Warwick
Malcolm G. Dunlop
Malcolm G. Dunlop University of Edinburgh
Richard Gray
Richard Gray University of Oxford
Stan B. Kaye
Stan B. Kaye Royal Marsden NHS Foundation Trust
Lauri A. Aaltonen
Lauri A. Aaltonen University of Helsinki
Jeremy Peter Cheadle
Jeremy Peter Cheadle Cardiff University
Polly A. Newcomb
Polly A. Newcomb Fred Hutchinson Cancer Research Center
Luis G. Carvajal-Carmona
Luis G. Carvajal-Carmona University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens the door to a wide range of healthcare careers—many of which now offer flexible online education options. If you’re considering alternative pathways or specialized roles in healthcare, several online degrees can help you get started or advance your career.

For those interested in nursing but concerned about entrance exams, you might ask, do you have to take a teas test for lpn? Some nursing schools allow students to apply without TEAS or HESI exams, making access more flexible. Aspiring healthcare leaders may consider a healthcare administration online degree to prepare for management roles in hospitals and clinics.

Registered nurses seeking to become Family Nurse Practitioners can accelerate their careers through adn to fnp programs, while those passionate about wellness and dietetics can pursue an online degree in nutrition for roles in clinical nutrition and public health.

Each of these pathways offers unique opportunities for career growth, job security, and the ability to make a real impact on patients’ lives—all from the convenience of online study.

Best Scientists Citing David J. Kerr

Trending Scientists

Recently Published Articles